Regulatory clarification on the use of nanoparticles in masks
.
.
.
10/06/2021
In a notice to operators, the DGCCRF and ANSM recalled some essential points to be considered before marketing surgical masks. In particular, the risks related to the presence of a biocidal substance or material must be assessed and that this assessment must take into account, among others, the particular risk of exposure to nanoparticles.
If the mask incorporates a nanomaterial, it will fall under Class IIa, IIb, or III with respect to internal exposure potential under Regulation (EU) 2017/745 on medical devices and this will therefore require the involvement of a notified body.
Our information sheets to go further
Other news on the topic
Upcoming Nano Agenda
27
Jan.
2026
Nanotechnologies and agriculture: a reference framework for responsible practice (AFNOR, online)
On line
Webinar
- Webconference for analysis laboratories, plant fertilizer manufacturers and distributors, public authorities…
- Moderated by David Krupka, nanotechnologies development manager at AFNOR Normalisation and Emilie Langlois-Bertrand, nantechnologies standardization project manager.
- In partnership with Armand Masion, CNRS Research Director, and Sandrine Mocoeur, Health, Safety, Environment and Quality Manager at SYNGENTA.
- This exchange will also be an opportunity to explore the creation of a national platform to identify standardization needs.
- Website: www.afnor.org/evenement/nanotechnologies-agriculture-cadre-pratique-responsable/
2
Juin
2026
Emerging pathologies and risks (CNMST 2026, Lyon – France)
Lyon
Congress
- 8th Congress of Occupational Medicine and Health (CNMST 2026)
- Theme 5: Emerging pathologies and risks, Mr Henri Bastos (ANSES), Pr Lynda Bensefa-Colas (AP-HP), Dr Catherine Nisse (CHU Lille)
- Website: www.medecine-sante-travail.com
26
Juin
2026
Nanomaterials and Health (ANSES, Maisons-Alfort)
Maisons-Alfort
Dialogue Committee
- 20th meeting of the “nano and health” dialogue committee
- Organizer: ANSES